Literature DB >> 28301577

Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0171356.].

Entities:  

Year:  2017        PMID： 28301577      PMCID： PMC5354437          DOI： 10.1371/journal.pone.0174493

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


In the article title, “Lap atinib” should be displayed as “Lapatinib.” The correct title is: Yes1 signaling mediates the resistance to Trastuzumab/Lapatinib in breast cancer. The correct citation is: Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, et al. (2017) Yes1 signaling mediates the resistance to Trastuzumab/Lapatinib in breast cancer. PLoS ONE 12(2): e0171356. doi:10.1371/journal.pone.0171356. The publisher apologizes for the error.
  1 in total

1.  Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

Authors:  Tatsuaki Takeda; Hiromasa Yamamoto; Hirotaka Kanzaki; Ken Suzawa; Takahiro Yoshioka; Shuta Tomida; Xiaojiang Cui; Ramachandran Murali; Kei Namba; Hiroki Sato; Hidejiro Torigoe; Mototsugu Watanabe; Kazuhiko Shien; Junichi Soh; Hiroaki Asano; Kazunori Tsukuda; Yoshihisa Kitamura; Shinichiro Miyoshi; Toshiaki Sendo; Shinichi Toyooka
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.